Emmaus Life Sciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Emmaus Life Sciences's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 11% to $20,610,000. Profit margin reached -77%. Total operating expenses were $23,426,000.

Profit Margin

Emmaus Life Sciences, Inc. (OTC:EMMAW): Profit margin
2012 115K -3.40M -2962.43%
2013 130.9K -10.88M -8317.8%
2014 135.1K -2.66M -1968.99%
2015 100.1K -3.38M -3382.62%
2016 85.1K -5.94M -6981.08%
2017 128.5K -7.11M -5535.25%
2018 1.31M -10.33M -785.49%
2019 22.75M -54.84M -241.04%
2020 23.16M 1.1M 4.75%
2021 20.61M -15.94M -77.37%

EMMAW Income Statement (2012 – 2021)

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
20.61M23.16M22.75M1.31M128.5K85.1K100.1K135.1K130.9K115K
Cost of revenue
3.31M2.24M1.09M827.4K53.5K5.5K4.9K73K142.6K132K
Gross profit
17.29M20.91M21.65M488.1K75K79.6K95.2K62.1K-11.7K-17K
Operating exp.
Research and development
4.11M2.40M2.18M1.37M1.36M794.2K783.8K1.45M1.28M853.7K
Selling and marketing
5.87M4.86M6.97M1.99M1.39M550.5K347.9K390.2K366.3K997.1K
Total operating expenses
23.42M20.95M26.17M10.73M7.17M3.84M2.75M3.87M4.18M4.78M
Operating income
-12.82M4.40M-27.28M-9.51M-7.10M-3.21M-3.11M-2.65M-9.61M-4.80M
Other income (expenses), net
-3.10M-3.68M-27.39M-820.7K-6.6K-2.72M-264K2.7K-1.26M1.89M
Income before tax
-15.92M719K-54.67M-10.33M-7.11M-5.93M-3.38M-2.65M-10.88M-2.91M
Income tax expense
25K-381K164K1.9K2.6K2K5K5.2K8001.9K
Net income
-15.94M1.1M-54.84M-10.33M-7.11M-5.94M-3.38M-2.66M-10.88M-3.40M
Earnings per share
Basic EPS
-0.320.02-1.11-0.21-0.14-0.12-0.06-0.05-0.220
Diluted EPS
-0.320.02-1.11-0.21-0.14-0.12-0.06-0.05-0.220
Data sourceData source